Study Title
OPTIMISE: Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer
Protocol ID
OPTIMISE
Condition/s
Bone Cancers
Brain and other CNS Tumours
Germ Cell Tumours
Hodgkin Lymphoma
Kidney (Renal) Tumours
Leukaemia
Liver tumours
Neuroblastoma
Non-Hodgkin Lymphoma
Retinoblastoma
Soft Tissue Sarcomas
Other
Brain and other CNS Tumours
Germ Cell Tumours
Hodgkin Lymphoma
Kidney (Renal) Tumours
Leukaemia
Liver tumours
Neuroblastoma
Non-Hodgkin Lymphoma
Retinoblastoma
Soft Tissue Sarcomas
Other
Diagnosis Stage
Relapsed/Recurrent
Location
NSW, QLD, VIC, WA
Links
Trial Status
Open
Sites
Queensland Children's Hospital
Sydney Children's Hospital
Royal Children's Hospital
Perth Children's Hospital
Sydney Children's Hospital
Royal Children's Hospital
Perth Children's Hospital
Study Type
Treatment
Phase
Phase 1/2
Age Eligibility
0 - 21 years
ANZCTR
NCT06208657
| Study Title | OPTIMISE: Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer |
|---|---|
| Protocol ID | OPTIMISE |
| Disease (Sub Disease) | Bone Cancers Brain and other CNS Tumours Germ Cell Tumours Hodgkin Lymphoma Kidney (Renal) Tumours Leukaemia Liver tumours Neuroblastoma Non-Hodgkin Lymphoma Retinoblastoma Soft Tissue Sarcomas Other |
| Diagnosis Stage | Relapsed/Recurrent |
| Location | NSW / QLD / VIC / WA |
| Links | https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=22171&isClinicalTrial=True |
| Trial Status | Open |
| Trial Open Date | 01/03/2024 |
| Sites | Queensland Children's Hospital / Sydney Children's Hospital / Royal Children's Hospital / Perth Children's Hospital/ |
| Study Type | Treatment |
| Phase | Phase 1/2 |
| Age Eligibility | 0 - 21 years |
| ANZCTR | NCT06208657 |